15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering AtriCure Inc, 7 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $48.00 to $64.00, so the covering firms are broadly aligned. The average target of $54.86 sits 2% above the current $53.74. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 6 to 7 over recent months. On the fundamentals, the Street sees revenue growth near 13% this year and 12% next, consensus EPS building from about $0.09 next quarter toward $0.43 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Strong Buy
Strong Buy00%
Buy788%
Hold113%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to AtriCure Inc.
As of Sep, 7 of 8 firms rate ATRC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ATRC EPS & revenue forecast
EPS · NEXT QUARTER
$0.09
Range $0.04 – $0.13 · 9 analysts · +46% YoY
Next period, 9 analysts expect AtriCure Inc to earn $0.09 a share (range $0.04 – $0.13), versus $0.06 a year earlier. Full-year consensus is $0.28, growing to $0.43 the year after.
REVENUE · NEXT QUARTER
$160.1M
Range $158.4M – $162.0M · 9 analysts · +13% YoY
Revenue is expected to reach $160.1M (range $158.4M – $162.0M), +13.0% year-over-year. Full-year consensus is $606.2M, rising to $679.6M next year.
Top analysts covering AtriCure Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ATRC.
#1
Mike Matson
Needham · Rank #210
Buy
$64.00+19.1% to target
Overall win rate
34%
+ Follow
#2
William Plovanic
Canaccord Genuity · Rank #243
Buy
$55.00+2.3% to target
Overall win rate
37%
+ Follow
#3
Matt O'Brien
Piper Sandler · Rank #424
Buy
$60.00+11.6% to target
Overall win rate
25%
+ Follow
#4
MT
Marie Thibault
BTIG
Buy
$55.00+2.3% to target
Coverage
—
+ Follow
#5
DS
Daniel Stauder
JMP Securities
Buy
$52.00-3.2% to target
Coverage
—
+ Follow
ATRC stock forecast FAQ
What is ATRC's average 12-month price target?+
The 7 analysts with a live target average $54.86 for AtriCure Inc over the next 12 months, ranging from a $64.00 high to a $48.00 low.
Is ATRC stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 8 analyst ratings, 7 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ATRC?+
The Street-high target is $64.00 (Needham), and the Street-low is $48.00 (JP Morgan). The average of all 7 active targets is $54.86.
How many Wall Street analysts cover ATRC?+
8 analysts have an active rating on AtriCure Inc, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering ATRC?+
Among analysts who currently cover ATRC, Mike Matson of Needham has the strongest overall Quantellect track record (Rank #210). Their current call is Buy with a $64.00 target.
What is AtriCure Inc's projected EPS for next quarter?+
The consensus estimate is $0.09 per share (range $0.04 – $0.13) across 9 analysts. Full-year EPS is projected at $0.28, rising to $0.43 the following year.
How much revenue is AtriCure Inc expected to report next quarter?+
Consensus revenue is $160.1M (range $158.4M – $162.0M). Full-year revenue is projected at $606.2M, growing to $679.6M next year.
Have analysts been upgrading or downgrading ATRC lately?+
As of Sep, 7 of 8 firms rate ATRC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ATRC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
